Additional European Equity News
Arkema (AKE FP) - Proposed to acquire Glenwood Private Equity's 54% stake in PI Advanced Materials for approx. EUR 728mln. (Newswires)
AstraZeneca (AZN LN) - Announces USD 400mln investment in reforestation and biodiversity in support of climate action and human health. (Newswires)
Bayer (BAYN GY) - BlueRock's neural stem cell therapy for Parkinson's disease is first in Phase I clinical trial with positive results. (Bayer)
Boohoo (BOO LN) - Wishes to record "serious concerns it has regarding conduct of board" of Revolution Beauty. (Newswires)
DSM (DSM NA) - Q2 2023 (EUR): Adj. EBITDA EUR 400mln-420mln, citing weakening of the vitamin market, which further deteriorated in June. (Newswires)
ENI (ENI IM) - Agreed to sell several oil assets in Congo Republic to Perenco, deal worth around USD 300mln. (Newswires)
Orpea (ORP FP) - Suspends trading in shares and bonds ahead of vote results. (Newswires)
Santander (SAN SM) - Reduced its share capital by 1.64% to cancel the share acquired in the share buy-back programme. (Newswires)
Shell (SHEL LN) - Norco, Louisiana refiner is scheduled to reutnr to normal production by Thursday, according to people familiar with plant operations. (Newswires)
Thales (HO FP) - Partners with Google Cloud to build new generative AI-powered security capabilities, aims to ensure data security. (Newswires)
Acciona (ANE SM) reiterated with Equal Weight at Morgan Stanley
Carrefour (CA FP) initiated with Overweight at Morgan Stanley
EDP Renovaveis (EDP PL) reiterated with Equal Weight at Morgan Stanley
28 Jun 2023 - 07:47- EquitiesBank Speaker- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts